Video

VIDEO: Meet Frankie and Sophie, the thyroid cancer–sniffing dogs


 

AT ENDO 2015

References

SAN DIEGO – Researchers at the University of Arkansas for Medical Sciences in Little Rock are teaching dogs to detect thyroid cancer from urine samples.

The dogs become alert on samples if they detect cancer, but remain passive if they don’t. The first graduate of the program, a German shepherd mix named Frankie, got it right in 30 of 34 cases, matching final surgical pathology results with a sensitivity of 86.6% and a specificity of 89.5%.

With results like those, it might not be too long before Frankie and his colleagues are providing inexpensive adjunct diagnostic services when test results are uncertain, and helping underserved areas with limited diagnostic capacity, the researchers noted.

At the Endocrine Society meeting, investigator Dr. Andrew Hinson shared clips of Frankie and another recent graduate, a border collie mix named Sophie, and explained the project’s next steps.

Frankie was rescued by principal investigator Dr. Arny Ferrando. Sophie and other dogs in the program were also rescued from local animal shelters.

More information is available at www.thefrankiefoundation.org.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

aotto@frontlinemedcom.com

Recommended Reading

Radioactive iodine may boost survival in papillary thyroid cancer
MDedge Hematology and Oncology
Men on androgen deprivation therapy not getting bisphosphonates
MDedge Hematology and Oncology
Vitamin D landscape marked by lack of consensus
MDedge Hematology and Oncology
Bisphosphonates may protect against endometrial cancer
MDedge Hematology and Oncology
Metabolic syndrome linked to increased risk for most endometrial cancer subtypes
MDedge Hematology and Oncology
Study aims to determine prognostic factors for subset of thyroid cancer patients
MDedge Hematology and Oncology
Breast cancer patients show poor adherence to cardiovascular, diabetes medications
MDedge Hematology and Oncology
Lenvima gets the FDA’s nod for differentiated thyroid cancer
MDedge Hematology and Oncology
Oral bisphosphonates linked with lower risk of endometrial cancer
MDedge Hematology and Oncology
Most thyroid nodules have favorable prognosis
MDedge Hematology and Oncology